Daniela Renedo1,2, Florencia Ferraro3,4,5, Agustín Ruiz Johnson3, Romina Argañaraz3, Sebastian Giovannini3,6, Joaquín Pérez Zabala3,7, Elena Zemma3, Beatriz Mantese3. 1. Department of Pediatric Neurosurgery, Hospital de Pediatría Juan P. Garrahan, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina. dadarenedo@gmail.com. 2. Department of Neurosurgery, School of Medicine, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina. dadarenedo@gmail.com. 3. Department of Pediatric Neurosurgery, Hospital de Pediatría Juan P. Garrahan, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina. 4. Department of Neurosurgery, School of Medicine, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina. 5. Department of Neurosurgery, Hospital Británico, Buenos Aires, Argentina. 6. Department of Neurosurgery, FLENI, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina. 7. Department of Neurosurgery, Hospital Central de San Isidro, Buenos Aires, Argentina.
Abstract
PURPOSE: To describe a case series of children with thalamic tumors treated at our institution in a 5-year period. METHOD: A retrospective and observational study was performed. The records of 15 patients between 2013 and 2018 were analyzed. RESULTS: From 2013 to 2018, 15 patients were treated at our institution. The male to female index was 1.5, and the median age was 8.9 (IQR 4.75-13). Seven (46%) tumors were left-sided, seven (46%) were right-sided, and one (6%) was bilateral. All patients were symptomatic at the time of treatment. Motor deficit was the most common form of presentation (73%). Gross-total resection was performed in two (13.3%) patients, subtotal resection was performed in two other patients (13.3%), and for the rest of the patients (73.3%), the chosen surgical approach was a stereotactic-guided biopsy. The average of procedures was 3.4, mostly related to the treatment for hydrocephalus. Twelve patients (80%) received treatment for hydrocephalus. Nine patients (75%) were treated with ventriculoperitoneal shunts, and four patients (33%) underwent endoscopic third ventriculostomy. High-grade tumors predominated. Grade IV tumors were diagnosed in six patients (40%), followed by grade III in four patients (26.6%), grade II in three (20%) patients, and grade I in two (13.3%) patients. Chemotherapy was given in 93% of the cases, being temozolomide, the most used drug. CONCLUSION: The clinical and surgical approaches for thalamic tumors in children have changed over time. At our institution, the lesser invasive surgical procedures are now being used more frequently.
PURPOSE: To describe a case series of children with thalamic tumors treated at our institution in a 5-year period. METHOD: A retrospective and observational study was performed. The records of 15 patients between 2013 and 2018 were analyzed. RESULTS: From 2013 to 2018, 15 patients were treated at our institution. The male to female index was 1.5, and the median age was 8.9 (IQR 4.75-13). Seven (46%) tumors were left-sided, seven (46%) were right-sided, and one (6%) was bilateral. All patients were symptomatic at the time of treatment. Motor deficit was the most common form of presentation (73%). Gross-total resection was performed in two (13.3%) patients, subtotal resection was performed in two other patients (13.3%), and for the rest of the patients (73.3%), the chosen surgical approach was a stereotactic-guided biopsy. The average of procedures was 3.4, mostly related to the treatment for hydrocephalus. Twelve patients (80%) received treatment for hydrocephalus. Nine patients (75%) were treated with ventriculoperitoneal shunts, and four patients (33%) underwent endoscopic third ventriculostomy. High-grade tumors predominated. Grade IV tumors were diagnosed in six patients (40%), followed by grade III in four patients (26.6%), grade II in three (20%) patients, and grade I in two (13.3%) patients. Chemotherapy was given in 93% of the cases, being temozolomide, the most used drug. CONCLUSION: The clinical and surgical approaches for thalamic tumors in children have changed over time. At our institution, the lesser invasive surgical procedures are now being used more frequently.
Authors: Giuseppe Cinalli; Daniel T Aguirre; Giuseppe Mirone; Claudio Ruggiero; Daniele Cascone; Lucia Quaglietta; Ferdinando Aliberti; Serena De' Santi; Maria Consiglio Buonocore; Anna Nastro; Pietro Spennato Journal: J Neurosurg Pediatr Date: 2017-12-22 Impact factor: 2.375
Authors: Zsila S Sadighi; Jennifer Zabrowski; Frederick A Boop; Alberto Broniscer; Amar Gajjar; Raja B Khan Journal: Pediatr Neurol Date: 2016-08-22 Impact factor: 3.372
Authors: Paul Steinbok; Chittur Viswanathan Gopalakrishnan; Alexander R Hengel; Aleksander M Vitali; Ken Poskitt; Cynthia Hawkins; James Drake; Maria Lamberti-Pasculli; Olufemi Ajani; Walter Hader; Vivek Mehta; P Daniel McNeely; Patrick J McDonald; Adrianna Ranger; Michael Vassilyadi; Jeff Atkinson; Scott Ryall; David D Eisenstat; Juliette Hukin Journal: Childs Nerv Syst Date: 2015-11-23 Impact factor: 1.475
Authors: Stephanie Puget; Darach W Crimmins; Matthew R Garnett; Jacques Grill; Ricardo Oliveira; Nathalie Boddaert; Alison Wray; Arielle Lelouch-Tubiana; Thomas Roujeau; Federico Di Rocco; Michel Zerah; Christian Sainte-Rose Journal: J Neurosurg Date: 2007-05 Impact factor: 5.115
Authors: Vladimír Beneš; Michal Zápotocký; Petr Libý; Jakub Táborský; Jana Blažková; Jana Blažková; David Sumerauer; Adéla Mišove; Ivana Perníková; Martin Kynčl; Lenka Krsková; Miroslav Koblížek; Josef Zámečník; Ondřej Bradáč; Michal Tichý Journal: Acta Neurochir (Wien) Date: 2022-01-19 Impact factor: 2.216